Inotiv Hit by Ransomware: 176 GB of Data Stolen, Operations Disrupted

U.S. pharmaceutical giant Inotiv has confirmed that it was the victim of a major ransomware attack, resulting in the theft of 176 gigabytes of sensitive data and significant disruptions to its operations.

The attack has been claimed by the Qilin ransomware group, which is known for targeting global companies in the healthcare and biotech industries.

🔎 What Happened

• Hackers infiltrated Inotiv’s network and exfiltrated 176GB of confidential data.
• Files reportedly include clinical trial results, internal communications, and employee records.
• Portions of the stolen data have already surfaced on the dark web.

📊 Impact on Operations

Inotiv stated that the attack has disrupted certain research and operational systems, forcing delays in multiple projects. While critical drug testing facilities remain functional, productivity has been affected.

🛡️ Response & Investigation

The company is working with cybersecurity experts and federal law enforcement to contain the breach and prevent further damage. Immediate actions include:

• Isolating affected systems
• Enhancing monitoring and detection tools
• Notifying potentially impacted employees and partners

⚠️ Industry-Wide Concern

The incident highlights the growing risks facing the pharmaceutical sector, which has become a prime target for ransomware gangs due to the high value of medical data and the critical nature of research operations.

➡️ Analysts warn that similar attacks are likely to increase unless stronger cyber defense measures are adopted across the healthcare and pharmaceutical industries.